Search clinical trials for: Fentanyl sublingual spray

Total 2906 results

M.D. Anderson Cancer Center
INSYS Therapeutics Inc

Terminated

Sublingual Fentanyl for the Management of Breakthrough Pain

Advanced Cancers

United States
M.D. Anderson Cancer Center
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain

Pain

United States
INSYS Therapeutics Inc

Withdrawn

Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting

Chronic Pain
Loyola University

Terminated

Sublingual Fentanyl and Procedural Burn Pain

Burn Pain

United States
INSYS Therapeutics Inc

Withdrawn

Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain

Acute Pain

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray in Opioid Naive Participants

Pharmacology

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects

Pharmacokinetics and Pharmacodynamics

United States
INSYS Therapeutics Inc

Completed

Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions

Bioavailability

United States
INSYS Therapeutics Inc
National Cancer Institute (NCI)

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Cancer

United States
INSYS Therapeutics Inc

Completed

Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

Pain | Cancer

United States, India, Canada
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Mucositis

United States
INSYS Therapeutics Inc

Completed

Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)

Pain

United States
Ain Shams University

Recruiting

Effect of Topical Airway Block on Hemodynamic Stability Post Induction of Anaesthesia in Cardiac Surgeries (hemodynamics)

Cardiac Surgery

Egypt
Johns Hopkins University
Cure Addiction Now

Recruiting

Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl (NBIM)

Opioid Use Disorder

United States
Simon Fraser University
University of British Columbia

Not yet recruiting

NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI (NO AD)

Spinal Cord Injuries | Autonomic Dysreflexia
People's Hospital of Anshun City of Guizhou Province

Not yet recruiting

Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR (SLIT)

Allergic Rhinitis

China
University of Texas at Austin

Not yet recruiting

Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair

Anxiety | Facial Laceration
Anica Crnkovic

Recruiting

Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children

Pain, Postoperative | Otitis Media

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
The Cleveland Clinic

Terminated

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

Knee Arthroscopy

United States
Pauls Stradins Clinical University Hospital

Completed

The Effect of Vitamin D Sublingual Spray on Vitamin D3 Levels in the Blood Compared to Other Forms of Vitamin D3

Vitamin D3 Deficiency

Latvia
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Seoul National University

Withdrawn

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Breakthrough Pain | Cancer Pain
Augusta University
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress) (NO-Stress)

Cardiovascular Disease

United States
M.D. Anderson Cancer Center
Depomed

Completed

Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
Rajavithi Hospital

Completed

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Pain, Breakthrough

Thailand
Ankara City Hospital Bilkent

Completed

Lidocaine Spray for Pain Control in Rib Fractures

Analgesia | Rib Fractures

Turkey
Pauls Stradins Clinical University Hospital

Completed

The Effects of a Sublingual Sprayable Microemulsion of Vitamin D on Inflammatory Markers in COVID-19 Patients

COVID-19 | Vitamin D Deficiency

Latvia
Aziende Chimiche Riunite Angelini Francesco S.p.A
Zak-Pharma Dienstleistung Ges.m.b.H.

Completed

Benzydamine in Sore Throat Pain Relief (BePaiR Study) (BePaiR)

Acute Sore Throat

Hungary, Poland, Russian Federation
M.D. Anderson Cancer Center
Archimedes Pharma US, Inc.

Terminated

Fentanyl for Breakthrough Pain in the Emergency Department

Pain

United States
M.D. Anderson Cancer Center

Completed

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

Pain | Advanced Cancers

United States
University of Minnesota

Completed

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

Pain | Pain, Acute | Anesthesia

United States
Prostrakan Pharmaceuticals

Completed

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

Pain | Cancer

United States
Norwegian University of Science and Technology
Maastricht University Medical Center; Fondazione IRCCS Istituto Nazionale dei... and other collaborators

Withdrawn

Nasal Fentanyl for Chronic Cancer Pain (NFCP-2)

Pain | Cancer
NPO Petrovax

Completed

Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI

Acute Respiratory Infection

Russian Federation
Azienda Sanitaria dell'Alto Adige
Institute of Mountain Emergency Medicine

Completed

Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope

Acute Pain Due to Trauma

Italy
Azienda Sanitaria dell'Alto Adige

Completed

Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room

Acute Pain Due to Trauma

Italy
Turku University Hospital

Completed

Procedural Pain Treatment With Transmucosal Sublingual Fentanyl Tablet in Colonoscopy Patients (Abstral)

Pain | Colonoscopy

Finland
McGill University

Unknown

Effect of Sublingual Fentanyl on Breathlessness in COPD

Copd
INSYS Therapeutics Inc

Completed

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

Pain, Postoperative

United States
University of Louisville
James Graham Brown Cancer Center

Withdrawn

An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients. (FCNS)

Pain

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Pain

United States
INSYS Therapeutics Inc

Terminated

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Post-operative Pain

United States
Orexo AB

Terminated

Conversion From Fast Acting Oral Opioids to Abstral®

Pain

Sweden
Defense and Veterans Center for Integrative Pain...
Depomed

Completed

Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints (RFA)

Minor Procedural Pain

United States
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio...
Consorzio Mario Negri Sud

Withdrawn

PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy (PERFECT FAST)

Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain

Italy
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
International Clinical Research Institute

Terminated

An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.

Breakthrough Pain

United States
Takeda

Completed

A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain (NOSE-400)

Cancer | Break Through Pain

Russian Federation, Hungary, Norway

3

Subscribe